Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol + amlodipine versus nebivolol or amlodipine monotherapy in grade 1-2 hypertension
2021-005077-10Phase 4Completed
- Sponsor
- Menarini Group
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nebivolol and amlodipine in hypertension (HTN) (3 arms), sponsored by Menarini Group. Started Mar 2022; status: completed.
02
Drugs
nebivololamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2021-005077-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005077-10.